PPARG and breast cancer: On the other hand, combined treatment with similar doses of γ-tocotrienol and GW9662 resulted in a significant decrease in PGD2 synthesis in PPARγ siRNA transfected MCF-7 and MDA-MB-231 breast cancer cells compared to vehicle-treated or scrambled RNA transfected cells (Figure 10(a)).